I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 1.085 USD 4.33% Market Closed
Market Cap: 87.8m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

I-Mab
Research & Development Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Research & Development
-ÂĄ810.6m
CAGR 3-Years
6%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Research & Development
-ÂĄ12.5B
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Research & Development
-ÂĄ1.1B
CAGR 3-Years
-54%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Research & Development
-ÂĄ192.9m
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Research & Development
-ÂĄ992.9m
CAGR 3-Years
-41%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Research & Development
-ÂĄ232.4m
CAGR 3-Years
-59%
CAGR 5-Years
-49%
CAGR 10-Years
N/A

See Also

What is I-Mab's Research & Development?
Research & Development
-810.6m CNY

Based on the financial report for Dec 31, 2023, I-Mab's Research & Development amounts to -810.6m CNY.

What is I-Mab's Research & Development growth rate?
Research & Development CAGR 5Y
-14%

Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for I-Mab have been 6% over the past three years , -14% over the past five years .

Back to Top